Quality of life and tracheostomy influence in successfully treated hypopharyngeal cancer: A case report

Vulcu Cordunianu,Alina-Georgiana; Ganea,Gabriel; Cordunianu,Mihai Alexandru; Cochior,Daniel

doi:10.3892/etm.2022.11118

Quality of life and tracheostomy influence in successfully treated hypopharyngeal cancer: A case report

Authors:
- Alina-Georgiana Vulcu Cordunianu
- Gabriel Ganea
- Mihai Alexandru Cordunianu
- Daniel Cochior
View Affiliations

Affiliations: Medicine Doctoral School, Titu Maiorescu University, 040317 Bucharest, Romania, ENT Department, Carol Davila Central University Emergency Military Hospital, 10825 Bucharest, Romania
Published online on: January 5, 2022 https://doi.org/10.3892/etm.2022.11118
Article Number: 195
Copyright: © Vulcu Cordunianu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Squamous cell carcinoma (SCC) of the hypopharynx is associated with the worst prognosis of all squamous cell cancer types of the head and neck, with a rich submucosal lymphatic network and a significant inferior extent. Generally, cancers of the head and neck have a big impact on the quality of life (QoL) in patients, both before and after treatment, due to the fact that most cases are diagnosed in advanced stages, with lymph node metastases and have an aggressive pattern associated with low survival rates. The present case report aimed to see the evolution of a patient successfully treated for hypopharyngeal cancer with conservation therapies from the QoL perspective and the influence made by the presence of tracheostomy. Variables, including clinical parameters (sex, age, TNM classification, performance status, histological type and tumor subsite), local control, QoL, Adult Comorbidity Evaluation‑27 score and overall survival were assessed, according to the American Joint Committee on Cancer 8th edition, for a 58‑year‑old patient treated with conservation therapies and tracheostomy in a tertiary center. Subjective features measured through the QoL questionnaire had scores with lowering tendencies during the treatment period. The patient was provided with early training for tracheostomy care and early discharge education. The following objective features of treatment response were exhibited: Hemoglobin levels, leukocyte count, tumor size, imagistic evaluations and local control to confirm treatment response. It is essential when planning the treatment of aggressive and rare pathologies, such as hypopharyngeal cancer, to consider the QoL and patient choice for better adherence. Overall, the results demonstrated that the initial requirement for emergency tracheostomy was not associated with any ulterior complications and did not influence the end result of the treatment.

View Figures

View References

1	Vila PM and Uppaluri R: Neoplasms of the hypopharynx and cervical esophagus. In: Cummings Otolaryngology Head and Neck Surgery. Flint PW and Cummings CW (eds). 6th edition, Vol II. pp1537-1553, Elsevier Saunders, Philadelphia, 2015.
2	Firkins J, Hansen L, Driessnack M and Dieckmann N: Quality of life in ‘cronic’ cancer survivors: A meta-analysis. J Cancer Survivorship. 14:504–517. 2020.PubMed/NCBI View Article : Google Scholar
3	Lewandowska A, Rudzki G, Lewandowski T, Prochnicki M, Rudzki S, Laskowska B and Brudniak J: Quality of life of cancer patients treated with chemotherapy. Int J Environ Res Public Health. 17(6938)2020.PubMed/NCBI View Article : Google Scholar
4	Machiels JP, René Leemans C, Golusinski W, Grau C, Licitra L and Gregoire V: EHNS Executive Board. Electronic address: simplesecretariat@ehns.org; ESMO Guidelines Committee. Electronic address: simpleclinicalguidelines@esmo.org and ESTRO Executive Board. Electronic address: simpleinfo@estro.org. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 31:1462–1475. 2020.PubMed/NCBI View Article : Google Scholar
5	Marchlang JL, Luce D, Leclerc A, Goldberg P, Orlowski E, Bugel I and Brugère J: Laryngeal and hypopharyngeal cancer and occupational exposure to asbestos and man-made vitreous fibers: Results of a case-control study. Am J Ind Med. 37:581–589. 2000.PubMed/NCBI View Article : Google Scholar
6	Laforest L, Luce D, Goldberg P, Begin D, Gerin M, Demers PA, Brugere K and Leclerc A: Laryngeal and hypopharyngeal cancers and occupational exposure to formaldehyde and various dusts: A case-control study in France. Occup Environ Med. 57:767–773. 2000.PubMed/NCBI View Article : Google Scholar
7	Neagu A, Mocanu A, Bonciu A, Coada G and Mocanu H: Prevalence of GJB2 gene mutations correlated to presence of clinical and environmental risk factors in the etiology of congenital sensorineural hearing loss of the Romanian population. Exp Ther Med. 21(612)2021.PubMed/NCBI View Article : Google Scholar
8	Petersen JF, Timmermans AJ, van Dijk BAC, Overbeek LIH, Smit LA, Hilgers FJM, Stuiver MM and van den Brekel MWM: Trends in treatment, incidence and survival of hypopharynx cancer: A 20-year population-based study in the Netherlands. Eur Arch Otorhinolaryngol. 275:181–189. 2018.PubMed/NCBI View Article : Google Scholar
9	Arends CR, Petersen JF, van der Noort V, Timmermans AJ, Leemans CR, de Bree R, Van den Brekel MWM and Stuiver MM: Survival predictions of hypopharynx cancer: Development of a clinical prediction model. Laryngoscope. 130:2166–2172. 2020.PubMed/NCBI View Article : Google Scholar
10	Monteiro AR, Garcia AR, Pereira TC, Macedo F, Soares RF, Pereira K, Serra T, Khouri L, Ribeiro J and Teixeira MM: ACE-27 as a prognostic tool of severe acute toxicities in patients with head and neck cancer treated with chemoradiotherapy: A real-world, prospective, observational study. Support Care Cancer. 29:1863–1871. 2021.PubMed/NCBI View Article : Google Scholar
11	Friedlander AH and Ettinger RL: Karnofsky performance status scale. Spec Care Dentist. 29:147–148. 2009.PubMed/NCBI View Article : Google Scholar
12	Singer S, Arraras JI, Chie WC, Fisher SE, Galalae R, Hammerlid E, Nicolatou-Galitis O, Schmalz C, Verdonck-de Leeuw I, Gamper E, et al: Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: A methodological review. Qual Life Res. 22:1927–1941. 2013.PubMed/NCBI View Article : Google Scholar
13	American Joint Committee on Cancer: Oropharynx and hypopharynx. In: AJCC Cancer Staging Manual. 8th edition. Springer, New York, NY, p16123-16135, 2017.
14	Seyman CC and Celik SS: Effect of protective cover on the quality of life of patients with tracheostomy-A quasi-experimental study. J Perianesth Nurs. 35:430–436. 2020.PubMed/NCBI View Article : Google Scholar
15	Colandrea M and Eckardt P: Improving tracheostomy care delivery: Instituting clinical care pathways and nursing education to improve patient outcomes. ORL Head Neck Nurs. 34:7–16. 2016.PubMed/NCBI
16	Lim SH, Sun JM, Hong J, Oh D, Ahn YC, Chung MK, Jeong HS, Son YI, Ahn MJ, Baek CH, et al: Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancer. Korean J Intern Med. 36 (Suppl 1):S217–S224. 2021.PubMed/NCBI View Article : Google Scholar
17	Yokota T, Shibata M, Hamauchi S, Shirasu H, Onozawa Y, Ogawa H, Onoe T, Kawakami T, Turuta M, Inoue H, et al: Feasibility and efficacy of chemoradiotherapy with concurrent split-dose cisplatin after induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for locally advanced head and neck cancer. Mol Clin Oncol. 13(35)2020.PubMed/NCBI View Article : Google Scholar
18	Pezdirec M, Strojan P and Boltezar IH: Swallowing disorders after treatment for head and neck cancer. Radiol Oncol. 53:225–230. 2019.PubMed/NCBI View Article : Google Scholar
19	Sherman AC, Simonton S, Adams DC, Vural E, Owens B and Hanna E: Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35). Arch Otolaryngol Head Neck Surg. 126:459–467. 2000.PubMed/NCBI View Article : Google Scholar
20	Gomes EPAA, Aranha AMF, Borges AH and Volpato LER: Head and Neck cancer Patients' quality of life: Analysis of three instruments. J Dent (Shiraz). 21:31–41. 2020.PubMed/NCBI View Article : Google Scholar
21	Milne S, Parmar J and Ong TK: Adult comorbidity Evaluation-27 as a predictor of postoperative complications, two-year mortality, duration of hospital stay, and readmission within 30 days in patients with squamous cell carcinoma of the head and neck. Br J Oral Maxillofac Surg. 57:214–218. 2019.PubMed/NCBI View Article : Google Scholar
22	Mocanu H, Mocanu AI, Drăgoi AM and Rădulescu M: Long-term histological results of ossicular chain reconstruction using bioceramic implants. Exp Ther Med. 21(260)2021.PubMed/NCBI View Article : Google Scholar
23	Caro JJ, Salas M and Goss G: Anemia as independent prognostic factor for survival in patients with cancer: A systemic, quantitative review. Cancer. 91:2214–2221. 2001.PubMed/NCBI
24	Danan D, Shonka DC Jr, Selman Y, Chow Z, Smolkin ME and Jameson MJ: Prognostic value of albumin in patients with head and neck cancer. Laryngoscope. 126:1567–1571. 2016.PubMed/NCBI View Article : Google Scholar